1. Share Prices

  2. Puretech Health PLC (PRTC)

140.00p+3.60 (+2.64%)24 Jan 2025, 17:06
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.AJ Bell logo
Jump to:

Puretech Health PLC Fundamentals

Company NamePuretech Health PLCLast Updated2025-01-24
IndustryBiotechnologySectorHealthcare
Shares in Issue239.421 mMarket Cap£335.19 m
PE Ratio227.27Dividend per Share0
Dividend Yield0Dividend Cover0
EPS-$0.24EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0.0414Debt Equity Ratio0.0520
Asset Equity Ratio1.8940Cash Equity Ratio1.6396
Quick Ratio3.6447Current Ratio3.68
Price To Book Value1.3106ROCE0

Puretech Health PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Puretech Health PLC Company Financials

Assets20232022
Tangible Assets$19.36 m$37.24 m
Intangible Assets$906,000.00$831,000.00
Investments$321.03 m$261.04 m
Total Fixed Assets$346.77 m$316.45 m
Stocks00
Debtors$2.38 m$11.87 m
Cash & Equivalents$327.14 m$350.10 m
Other Assets$5.48 m$17.35 m
Total Assets$693.97 m$702.65 m
Liabilities20232022
Creditors within 1 year$51.37 m$96.89 m
Creditors after 1 year$184.37 m$58.17 m
Other Liabilities00
Total Liabilities$235.74 m$155.06 m
Net assets$458.23 m$547.59 m
Equity20232022
Called up share capital$5.46 m$5.46 m
Share Premium$290.26 m$289.62 m
Profit / Loss-$36.10 m-$92.78 m
Other Equity$464.07 m$542.22 m
Preference & Minorities-$5.83 m$5.37 m
Total Capital Employed$458.23 m$547.59 m
Ratios20232022
Debt Ratio$0.04$0.06
Debt-to-Equity$0.04$0.06
Assets / Equity1.89401.8940
Cash / Equity1.63961.6396
EPS-$0.57-$0.52
Cash Flow20232022
Cash from operating activities-$105.92 m-$178.79 m
Cashflow before financing-$27.78 m-$208.62 m
Increase in Cash$41.22 m-$315.84 m
Income20232022
Turnover$750,000.00$2.09 m
Cost of sales00
Gross Profit00
Operating Profit-$146.20 m-$197.81 m
Pre-Tax profit-$36.10 m-$92.78 m

Puretech Health PLC Company Background

SectorHealthcare
ActivitiesPureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Wholly-Owned Programs, Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.
Latest Interim Date28 Aug 2024
Latest Fiscal Year End Date25 Apr 2024

Puretech Health PLC Directors

AppointedNamePosition
2020-08-27Dr. Bennett M. ShapiroNon-Executive Director
2024-03-06Dr. Bharatt M. ChowriraExecutive Director,Chief Executive Officer
2024-10-31Dr. John L. LaMattina, PhDNon-Executive Director
2024-06-27Dr. Robert S. Langer, Sc.D.Non-Executive Director
2024-06-27Dr. Raju S. KucherlapatiNon-Executive Director,Chairman
2019-09-09Mr. Joichi ItoNon-Executive Director,Chairman
2022-12-28Dame Marjorie Morris ScardinoNon-Executive Director,Senior Independent Director
2024-04-25Mr. Christopher ViehbacherNon-Executive Director,Chairman
2024-06-27Ms. Kiran Mazumdar ShawNon-Executive Director
2024-04-09Ms. Daphna ZoharExecutive Director,Chief Executive Officer
2021-01-29Mr. Stephen MunizExecutive Director,Chief Operating Officer and Company Secretary
2024-06-27Ms. Sharon Barber-LuiNon-Executive Director

Puretech Health PLC Contact Details

Company NamePureTech Health PLC
Address6 St Andrew Street, 5th Floor, London, EC4A 3AE
Telephone
Websitehttps://www.puretechhealth.com

Puretech Health PLC Advisors

StockbrokerPeel Hunt LLP
Phone+44 2074188900
StockbrokerJefferies Hoare Govett
Phone+44 2070298000
Fax+44 2070298010
StockbrokerNumis Securities Limited
Phone+44 2072601000
Remuneration ConsultantNew Bridge Street
Phone+44 2070869341
Fax+44 2070869341
Financial PR AdviserFTI Consulting Inc
Phone+44 2037271000
Fax+44 2037271007
AuditorKPMG
Phone+44 2073111000
Fax+44 2073113311
SolicitorDLA Piper LLP
Phone+44 8700111111
Fax+44 2077966666
RegistrarComputershare Investor Services PLC
Phone+44 3707020003
Fax+44 3707036101

Most Read

Receive our
daily news email

Subscribe to the latest investing news by entering your email address below

You can opt out at any time.

For five days a week you will get

  • The latest company news
  • Insight into investment trends
  • Round-up of director's buys and sells
  • Articles from Shares magazine
Sharesmagazine cover

Plus more useful investment content and occasional promotional offers.

Shares Magazine Latest Issue Cover
Latest Issue:
23 Jan 2025Subscribe now

Market Overview

UK 350 Risers and Fallers

Risers

CompanyPrice% Chg
Burberry Group PLC1,176.009.86
Kainos Group PLC805.005.09
Diageo PLC2,503.504.25
Babcock International Group PLC519.503.69
Pets AT Home Group PLC211.003.33
Jd Sports Fashion PLC84.002.82

Fallers

CompanyPrice% Chg
Harbour Energy PLC254.10-7.73
Energean PLC963.50-5.07
Diversified Energy Company PLC1,273.00-3.41
Marks And Spencer Group PLC321.50-3.40
Ocado Group PLC303.10-3.19
AJ Bell PLC458.50-3.17
Risers/fallers data from previous trading day. Today's data available from 8:15am.